Home/InMed Pharmaceuticals/Bruce S. Colwill
BS

Bruce S. Colwill

Chief Financial Officer

InMed Pharmaceuticals

Therapeutic Areas

InMed Pharmaceuticals Pipeline

DrugIndicationPhase
INM-755Epidermolysis Bullosa (wound care)Phase 2
INM-088GlaucomaPreclinical